Safety and Efficacy of ORM-12741 in Patients With Alzheimer's Disease

• Status: Completed
• Trial end date: 2012-10-01

Summary

The purpose of this study is to determine whether ORM-12741 is safe and effective in the treatment of Alzheimer's disease.

• Phase: Phase 2

Details

• Lead Sponsor: Orion Corporation, Orion Pharma